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he p16
 
INK4a
 
–RB pathway plays a critical role in pre-
venting inappropriate cell proliferation and is often
targeted by viral oncoproteins during immortalization.
Latent membrane protein 1 (LMP1) of Epstein-Barr virus
(EBV) is often present in EBV-associated proliferative diseases
and is critical for the immortalizing and transforming activity
of EBV. Unlike other DNA tumor virus oncoproteins, which
possess immortalizing activity, LMP1 does not bind to retino-
blastoma tumor suppressor protein, but instead blocks the
expression of p16
 
INK4a
 
 tumor suppressor gene. However, it
has been unclear how LMP1 represses the p16
 
INK4a
 
 gene
expression. Here, we report that LMP1 promotes the CRM1-
dependent nuclear export of Ets2, which is an important
T
 
transcription factor for p16
 
INK4a
 
 gene expression, thereby
 
reducing the level of p16
 
INK4a
 
 expression. We further demon-
strate that LMP1 also blocks the function of E2F4 and E2F5
(E2F4/5) transcription factors through promoting their nuclear
export in a CRM1-dependent manner. As E2F4/5 are essential
downstream mediators for a p16
 
INK4a
 
-induced cell cycle
arrest, these results indicate that the action of LMP1 on
nuclear export has two effects on the p16
 
INK4a
 
–RB pathway:
(1) repression of p16
 
INK4a
 
 expression and (2) blocking the
downstream mediator of the p16
 
INK4a
 
–RB pathway. These
results reveal a novel activity of LMP1 and increase an under-
standing of how viral oncoproteins perturb the p16
 
INK4a
 
–
RB pathway.
 
Introduction
 
It is well accepted that immortalization is one of the hall-
marks of cancer cells (DePinho, 2000; Lundberg et al., 2000;
Campisi, 2001). Cells in primary culture undergo irreversible
growth arrest, termed cellular senescence when cultured
cells reach the end of their replicative lifespan (Hayflick
and Moorhead, 1961). It has recently become evident that
a similar phenotype can be induced when primary cells are
challenged by an activated Ras oncogene or its downstream
mediators, Raf and MAPK/ERK kinase (MEK;* Serrano et
al., 1997; Lin et al., 1998; Zhu et al., 1998). This phe-
nomenon, termed “Ras-induced senescence,” is proposed
to be a fail-safe mechanism, which protects normal cells
from uncontrolled cell proliferation and tumor formation
(Serrano et al., 1997; Weinberg, 1997; Serrano and Blasco,
2001; Sotillo et al., 2001; Drayton and Peters, 2002; Lloyd,
2002). In each case, the arrest is accompanied by induction
of p16
 
INK4a
 
, an inhibitor of Cdks, and accumulation of the
unphosphorylated form of the retinoblastoma tumor sup-
pressor protein
 
 
 
(pRB) (Stein et al., 1990; Alcorta et al.,
1996; Hara et al., 1996; Serrano et al., 1997; Stein et al.,
1999). Moreover, ectopic expression of p16
 
INK4a
 
 alone is
sufficient to induce features of cellular senescence in human
fibroblasts (McConnell et al., 1998). Therefore, p16
 
INK4a
 
 is
thought to be a key mediator of cellular senescence at least
in human fibroblasts. The p16
 
INK4a
 
–RB pathway plays a
critical role in preventing inappropriate cell proliferation
and is often targeted by viral oncoproteins during immor-
talization (Jansen-Durr, 1996; Sherr, 1996; Hunter, 1997;
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Kiyono et al., 1998; Nevins, 2001; Classon and Harlow,
2002; Ortega et al., 2002).
Epstein-Barr virus (EBV) is a prevalent human 
 
 
 
 herpes
virus. It is frequently associated with a number of hu-
man  proliferative and malignant diseases, including Bur-
kitt’s lymphoma, nasopharyngeal carcinoma, Hodgkin’s lym-
phoma, and gastric carcinoma (for review see Farrell, 1995;
Thorley-Lawson, 2001). Nine viral oncoproteins are ex-
pressed in EBV-established lymphoblastoid cell lines, five of
which appear to be absolutely required for B cell immortal-
ization (Hammerschmidt and Sugden, 1989, Cohen et al.,
1991; Kaye et al., 1993; Tomkinson et al., 1993; Kilger et
al., 1998). Among these oncoproteins, latent membrane
protein 1 (LMP1) has been shown to transform established
rodent fibroblasts and immortalize primary rodent fibro-
blasts (Wang et al., 1985; Yang et al., 2000a,b; Eliopoulos
and Young, 2001). Unlike other DNA tumor virus onco-
proteins, which possess immortalizing activity, such as hu-
man papillomavirus E7 or adenovirus E1A (Jansen-Durr,
1996; Classon and Harlow, 2002), LMP does not bind to
the pRB family proteins. Recently, LMP1 was shown to
block the induction of p16
 
INK4a
 
 and to prevent Ras-induced
senescence in human fibroblasts, suggesting that the p16
 
INK4a
 
could be an important target of LMP1 in fibroblasts (Yang
et al., 2000b). However, until now, it has been unclear how
LMP1 blocks induction of p16
 
INK4a
 
 expression in primary
human fibroblasts.
To obtain mechanistic insight into how LMP1 inhibits
p16
 
INK4a
 
 expression, we examined the effect of LMP1 on
Ets2, which is an important transcription factor inducing
p16
 
INK4a
 
 expression in Ras-induced senescence (Ohtani et
al., 2001). Here, we report that LMP1 inactivates Ets2 by
promoting the intracellular redistribution of Ets2 from the
nucleus to the cytoplasm in a CRM1-dependent manner.
Furthermore, we find here that LMP1 also inactivates E2F4
and E2F5 (E2F4/5), which are essential downstream media-
tors of the p16
 
INK4a
 
–RB growth arrest pathway (Gaubatz et
al., 2000), also through promoting the CRM1-dependent
intracellular redistribution of E2F4/5. These findings reveal
a novel activity of the LMP1 oncoprotein and would facili-
tate understanding of how LMP1 oncoprotein of EBV per-
turbs p16
 
INK4a
 
–RB pathway.
 
Results
 
Inhibition of Ets2 transcriptional activity by LMP1
 
We have demonstrated previously that the activation of
Ets2, which is a downstream mediator of the MAPK cas-
cade, is responsible for the up-regulation of p16
 
INK4a
 
 in Ras-
induced senescence, whereas Ets1 seems to play a role in rep-
licative senescence (Ohtani et al., 2001; Huot et al., 2002).
Thus, we first tested whether LMP1 prevents p16
 
INK4a
 
 ex-
pression by blocking Ets2 activity. As shown previously
(Yang et al., 2000b), coexpression of LMP1 significantly
blocked the induction of p16
 
INK4a
 
 by oncogenic Ras in hu-
man diploid fibroblasts (HDFs; Fig. 1 A, lane 2). Like a
dominant negative form of Ets2 (E2DBD; Foos et al.,
1998), expression of LMP1 inhibited transcriptional activity
of Ets2 on the human p16
 
INK4a
 
 promoter and on an artificial
promoter (E36) containing tandem repeats of the Ets-bind-
 
ing sequence (Fig. 1 B). Moreover, chromatin-immunopre-
cipitation (ChIP) analysis indicated that Ets2 was not bound
to the p16
 
INK4a
 
 promoter in HDFs expressing LMP1 (Fig. 1
C, lanes 2 and 5). However, the level of Ets2 protein was
unaffected by LMP1 expression in HDFs (Fig. 1 A). These
results strongly suggest that LMP1 blocks Ets2 binding to
DNA without affecting the expression level of Ets2.
 
LMP1 induces the CRM1-dependent nuclear export 
of Ets2
 
Because the LMP1 protein localizes to the cytoplasm
(Eliopoulos and Young, 2001), we next asked how LMP1
blocks Ets2 binding to the p16
 
INK4a
 
 promoter. We examined
the subcellular localization of ectopically expressed Ets2 pro-
tein in the presence or absence of LMP1 in the human fibro-
blast cell line, SVts8 cells. In most of the cells, flag-tagged
Ets2 is expressed either in the nucleus or in the nucleus and
cytoplasm (Fig. 2 A, 1). Coexpression with GFP-tagged
LMP1, however, resulted in the accumulation of Flag-tagged
Ets2 in the cytoplasm (Fig. 2 A, 2). Similar results were ob-
tained using nontagged Ets2 and nontagged LMP1 expres-
Figure 1. LMP1 blocks Ets2 binding to DNA. (A) Early passage 
(38 PDLs) HDFs expressing ecotropic receptor were infected with 
a retrovirus encoding H-RasV12 and sequentially infected with a 
retrovirus encoding LMP1 (lane 2) or control vector (lane 1). 4 d 
after superinfection, levels of a series of endogenous proteins were 
examined by immunoblotting using antibodies shown right. MEK 
was used here as a loading control. (B) Dose-dependent ability of 
LMP1 and E2DBD to block activation of the p16
INK4a promoter (left) 
or E36 promoter (right) by Ets2 and activated MEK in SVts8 cells. 
Expression plasmids encoding proteins shown bottom were introduced 
into SVts8 cells along with 0.2  g of MMLV-lacZ plasmid. Luciferase 
activities were normalized by lac-Z activities. Error bars indicate 
SD. (C) ChIP assays were performed using cells described in A and 
antibody against Ets2 or SEI-1 (control). The p16
INK4a-promoter was 
recovered by PCR using primers flanking the Ets binding sites in the 
human p16
INK4a promoter.T
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sion vectors (unpublished data). This effect was blocked by
treatment with leptomycin B (LMB; Fornerod et al., 1997;
Stade et al., 1997; Kudo et al., 1998), a specific inhibitor of
CRM1-dependent nuclear export (Fig. 2 A, 3). In contrast,
overexpression of GFP-tagged CRM1 resulted in the accu-
mulation of Ets2 in the cytoplasm (unpublished data), sug-
gesting that these effects were mediated through a CRM1-
dependent nuclear export mechanism. These effects were
specific to Ets2, because LMP1 expression did not have any
significant impact on the subcellular localization of other
transcription factor, such as JunB (Fig. 2 B, 1 and 2), Elk1,
or p53 (not depicted). Moreover, LMP1 failed to promote
nuclear export of p27
 
Kip1
 
, which is known as a nuclear shut-
tling protein (Tomoda et al., 1999; Rodier et al., 2001;
Ishida et al., 2002; Fig. 2 B, 3 and 4). Furthermore, another
p16
 
INK4a
 
 repressor, Id1 (Lyden et al., 1999; Ohtani et al.,
2001), did not have any impact on the subcellular localiza-
tion of Ets2 (Fig. 2 A, 4). To confirm that these effects were
not due to transfection artifacts, nor limited to this cell line,
the subcellular localization of Ets2 was examined using an
Ecdyson-inducible vector encoding GFP-tagged LMP1 in
the TIG-3 strain of primary HDFs. Although nuclear stain-
ing of Ets2 was predominantly observed in the absence of the
Ecdysone analogue, Muristeron A (Fig. 2 C, 1), cytoplasmic
staining of Ets2 was predominantly observed in the signifi-
cant percentage of the cells when the expression of GFP-
tagged LMP1 was induced by the addition of the Muristeron
A (Fig. 2 C, 2). These results strongly suggest that LMP1 re-
Figure 2. LMP1 promotes cytoplasmic accumulation of Ets2. 
(A) Flag-tagged Ets2 was expressed alone (1) or coexpressed 
with GFP-tagged LMP1 (2 and 3) or Id1 (4) in SVts8 cells, as 
indicated. Flag-tagged Ets2 was detected by immunostaining 
with an anti-Flag antibody. Expression of Id1 was confirmed by 
immunostaining with polyclonal anti-Id1 antibody. Cells were 
treated with 2.5 ng/ml of LMB (3). The histograms on the right 
side of the micrographs indicate the percentage of nuclei that 
were positive (N ) or negative (N ) for Ets2 expression. Arrows 
indicate cells expressing Flag-tagged Ets2 alone (1) or cells 
expressing both Flag-tagged Ets2 and GFP-tagged LMP1 (2 and 
3) or cells expressing both Flag-tagged Ets2 and Id (4). (B) Flag-
tagged JunB (1) or p27
Kip1 (3) was expressed alone or coexpressed 
with GFP-tagged LMP1 (2 and 4) in SVts8 cells, as indicated. 
Flag-tagged JunB and p27
Kip1 were detected by immunostaining 
with an anti-Flag antibody. Histograms on the right side of the 
micrographs indicate the percentage of nuclei that were positive (N ) or negative (N ) for Flag-tagged protein expression. Arrows indicate 
cells expressing Flag-tagged protein alone (1 and 3) or cells expressing both Flag-tagged protein and GFP-tagged–LMP1 (2 and 4). (C) Flag-
tagged Ets2 expression vector (pRc/RSV; Invitrogen) was cotransfected with an Ecdyson-inducible vector encoding GFP-tagged LMP1 (pIND; 
Invitrogen) into early passage (38 PDLs) TIG-3 cells. Expression of GFP-tagged LMP1 was induced by addition of 0.5  g/ml of Ecdyson 
homologue, Muristeron A (panel 2). Flag-tagged Ets2 was detected with an anti-Flag antibody 2 d after addition of Muristeron A. Histograms 
on the right side of the micrographs indicate the percentage of nuclei that were positive (N ) or negative (N ) for Flag-tagged protein 
expression. Arrows indicate cells expressing Flag-tagged Ets2 alone (1) or cells expressing both Flag-tagged Ets2 and GFP-tagged LMP1 (2). 
For all panels, error bars indicate SD.T
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presses p16
 
INK4a
 
 expression through, at least partly, blocking
the nuclear localization of Ets2 transcription factor.
 
LMP1 targets downstream mediators of 
the p16
 
INK4a
 
-induced growth arrest pathway
 
If repression of p16
 
INK4a
 
 expression is the major function of
LMP1 in blocking the p16
 
INK4a
 
–RB pathway, ectopic ex-
pression of p16
 
INK4a
 
 should be dominant over the LMP1
function. To test this idea, we used the U2OS cells that have
been engineered to induce p16
 
INK4a
 
 expression by addition
of IPTG (EH1 cells; McConnell et al., 1999). As shown pre-
viously (McConnell et al., 1999), IPTG treatment signifi-
cantly blocks entry into S-phase (Fig. 3 A, lanes 1 and 2).
However, surprisingly, the ability of p16
 
INK4a
 
 to induce a G1
arrest was significantly attenuated when LMP1 was coex-
pressed as seen in CRM1-expressing cells (Fig. 3 A, lanes
3–6). Induction of p16
 
INK4a
 
 is similarly observed in both
LMP1-expressing cells and in control cells expressing GFP
(Fig. 3 B, lanes 2 and 4). Moreover, phosphorylation of the
pRB family proteins was blocked by the induction of the
p16
 
INK4a
 
 in both cases (Fig. 3 B, lanes 2 and 4), showing that
p16
 
INK4a
 
 is effectively functioning as a Cdk inhibitor in
LMP1 expressing cells. These results led us to hypothesize
that LMP1 also targets downstream mediator(s) of the
p16
 
INK4a
 
-induced growth arrest pathway.
 
LMP1 induces the CRM1-dependent nuclear export 
of E2F4/5
 
Recent reports suggest that E2F4/5 mainly act as “repressor”
E2Fs, which have opposing functions against “the activator”
E2Fs, E2F1–3 (Trimarchi and Lees, 2002). Mouse embry-
onic fibroblasts (MEFs) lacking both repressor E2Fs, E2F4/5,
grow normally but are insensitive to a p16
 
INK4a
 
-induced
G1 arrest (Gaubatz et al., 2000). Moreover, enforced nu-
clear export of E2F4/5 by overexpression of CRM1 prevents
the ability of p16
 
INK4a
 
 to induce a G1 arrest in U2OS cells
(Gaubatz et al., 2001). This evidence strongly suggests that
E2F4/5 are essential downstream mediators of the p16
 
INK4a
 
-
induced growth arrest pathway (Gaubatz et al., 2000).
Therefore, we tested if LMP1 has any effect on the subcellu-
lar localization of E2F4 and/or E2F5, which have previously
been shown to be regulated by CRM1-dependent nuclear
export machinery (Gaubatz et al., 2001; Trimarchi and
Lees, 2002). Although 50–60% of cells expressed transfected
E2F4/5 in both cytoplasm and nucleus under normal prolif-
erating conditions, coexpression of LMP1 significantly abol-
ished the nuclear localization of E2F4/5 in Svts8 cells (Fig.
4, A and B, 1 and 2). As reported previously (Gaubatz et al.,
2001), similar effects were seen by ectopic expression of
CRM-1 (Fig. 4, A and B, 3). This cytoplasmic accumulation
was blocked by the addition of LMB (Fig. 4, A and B, 4), in-
dicating that LMP1 also promotes intracellular redistribu-
tion of E2F4/E2F5 from the nucleus to the cytoplasm in a
CRM1-dependent manner. To obtain further proof of the
inactivation of E2F4/5 by LMP1, we monitored the tran-
scriptional activity of E2F4/5 using the human Rb gene pro-
moter, which is known to be a target of E2F4 (Ren et al.,
2002). Although E2F4/E2F5 induced Rb gene promoter ac-
tivity, this was abolished when LMP1 was coexpressed, sug-
gesting that the transcriptional activity of E2F4/5 is indeed
blocked by LMP1 (Fig. 4 C, 5–8).
To examine whether this is also the case for the endoge-
nous proteins, we have established an LMP1-inducible cell
line using an Ecdyson-inducible vector. The level of LMP1
induced in this cell line was similar to the levels expressing in
EBV-positive human B cells (Fig. 5 A, lanes 2 and 4), sug-
gesting that the levels of LMP1 in this cell line is likely to be
a physiological level. Because the levels of both endogenous
Ets2 and endogenous E2F4 were under detectable level by
immunofluorescence in this cell line, we examined the levels
of both proteins in isolated nuclear and cytoplasmic frac-
tions in the presence or absence of LMP1 expression by
immunoblotting. As shown in Fig. 5 B, the levels of en-
dogenous Ets2 and E2F4 in the nuclear fraction were sig-
nificantly reduced in cells expressing LMP1 (Fig. 5 B,
lanes 3 and 4). Moreover, similar results were obtained using
TIG-3 cells expressing LMP1 using a retroviral vector (Fig.
5 C, lanes 3 and 4). Although we were unable to examine
endogenous E2F5 due to lack of an antibody, these results
strongly suggest that LMP1 induces intracellular redistribu-
tion of endogenous Ets2 and E2F4/5 from the nucleus to
the cytoplasm in human fibroblasts. To test whether this is
also the case under the physiological condition of EBV in-
fection, we examined the subcellular localization of endoge-
nous E2F4 in Burkitt lymphoma cells that are positive or
negative for EBV infection. As shown in Fig. 5 D, signifi-
cant levels of E2F4 were observed in both nuclear and cyto-
plasmic fractions of EBV-negative Burkitt lymphoma cell
line, BL41 cells. However, we were unable to detect E2F4 in
the nuclear fraction of the BL41
 
   
 
B95 cells, which are ex-
perimentally infected with EBV (Fig. 5 D, lane 4). Ets2 lev-
els were under detectable levels in these cell lines (unpub-
lished data). These results further support the idea that
Figure 3. LMP1 blocks downstream mediators of the p16
INK4a 
pathway. (A) The p16
INK4a inducible cell line, EH1 cells (McConnell 
et al., 1999), were transfected with an expression plasmid encoding 
GFP-tagged LMP1 or GFP-tagged CRM1 or a control vector expressing 
GFP alone. 12 h later, cells were treated with ( ) or without ( ) 
1 mM IPTG for p16
INK4a induction. 48 h after IPTG treatment, cells 
were labeled with BrdU for 1 h, fixed, and stained with an anti-BrdU 
antibody. Transfected cells were identified by their green fluorescence, 
and the percentages of cells that incorporated BrdU compared with 
the cells without induction of p16
INK4a were determined. (B) EH1 
cells were transfected with an expression plasmid encoding GFP-
tagged LMP1 or a control vector expressing GFP alone. 12 h later, 
cells were treated with ( ) or without ( ) 1 mM IPTG for p16
INK4a 
induction. 48 h after IPTG treatment, GFP-positive cells were isolated 
by FACS
® and cell lysates were immunoblotted with antibodies 
shown right. Error bars indicate SD.T
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LMP1 affects the intracellular location of Ets2 and E2F4/5
under the physiological condition.
 
LMP1 induces dissociation of E2F4 
from pRB family proteins
 
To seek mechanistic insight into how LMP1 promotes in-
tracellular redistribution of Ets2 and E2F4/5 from the nu-
cleus to the cytoplasm, we decided to focus our attention on
E2F4, because E2F4 contains typical nuclear export signal
(NES) sequences and is well established as a nuclear shut-
tling protein (Gaubatz et al., 2001; Trimarchi and Lees,
2002). Because E2F4/5 lack an NLS, it has been suggested
that association with an NLS-containing protein, such as
pRB family proteins or with DP2, plays important roles in
the nuclear localization of E2F4 (Muller et al., 1997; Ve-
rona et al., 1997). Furthermore, a recent report from Ray-
man and co-workers has shown that E2F4 is localized only
in the cytoplasm of MEFs lacking both p107 and p130
(Rayman et al., 2002), suggesting that the association with
p107 or p130 are required for the nuclear localization of
E2F4. Therefore, we tested if LMP1 blocks the interaction
 
between endogenous E2F4 and endogenous pRB family
proteins. As shown in Fig. 6 A, the interaction between en-
dogenous E2F4 and endogenous p107 was significantly re-
duced if LMP1 expression was induced in the LMP1-
inducible cell line. Similarly, the interaction between
endogenous E2F4 and endogenous pRB was also inhibited
by LMP1 expression (Fig. 6 A, lanes 1 and 2). These effects
were not observed in the control cells, which do not induce
LMP1 expression by the addition of Ecdyson homologue,
Ponasteron A (Fig. 6 B, lanes 1 and 2), precluding the pos-
sibility that these effects were caused by the Ponasteron A
treatment. We were unable to see interaction between E2F4
and p130 in this cell line (unpublished data). These effects
were not due to the phosphorylation of pRB family proteins
by Cdks, because we were unable to see any difference of
the phosphorylation pattern of pRB and p107 in the pres-
ence or absence of LMP1 expression (Fig. 6 A, lanes 1 and
2). To examine whether or not dissociation of E2F4 from
the NLS-containing protein is required for intracellular re-
distribution of E2F4 from the nucleus to the cytoplasm,
E2F4 was fused to the NLS sequence and coexpressed with
Figure 4. LMP1 induces cytoplasmic accumulation of E2F4/5. (A and B) E2F4 (A) or 
HA-tagged E2F5 (B) was expressed alone (1) or coexpressed with GFP-tagged LMP1 (2 and 4) 
or GFP-tagged CRM1 (3) in SVts8 cells. E2F4 was detected by immunostaining with anti-E2F4 
antibody and HA-tagged E2F5 was determined by immunostaining with anti-HA antibody. 
Cells were treated with 2.5 ng/ml of LMB (4). Histograms on the right side of the micrographs 
indicate the percentage of nuclei that were positive (N ) or negative (N ) for E2F4/5 
expression. (A and B) Arrows indicate cells expressing E2F alone (1) or cells expressing 
both E2F and GFP-tagged LMP1 (2 and 4) or cells expressing both E2F and GFP-tagged 
CRM1 (3). (C) Activation of the human Rb gene promoter by E2F4 or E2F5 was blocked by 
coexpression of LMP1 in SVts8 cells. Expression plasmids encoding the indicated proteins 
were introduced into SVts8 cells along with 0.7  g of Rb gene promoter–luciferase construct 
and with 0.2  g of MMLV-lacZ plasmid. Luciferase activities were normalized by lac-Z 
activities. For all panels, error bars indicate SD.T
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LMP1. As shown in Fig. 6 C, the NLS–E2F4 fusion pro-
tein is predominantly expressed in the nucleus and is resis-
tant to LMP1-induced cytoplasmic accumulation. This is
suggesting that dissociation of E2F4 from the NLS-con-
taining protein is required for the LMP1-induced intracel-
lular redistribution of E2F4. However, it is still possible
that dissociation of E2F4 from pRB family proteins is a
consequence of the cytoplasmic accumulation of E2F4 and
does not have a causal role in promoting nuclear export of
E2F4. Indeed, LMB treatment abolished LMP1-induced
cytoplasmic accumulation of E2F4 (Fig. 4 A). Moreover,
the mutation of NES sequences (Gaubatz et al., 2001) ac-
cumulated E2F4 in the nucleus and made E2F4 less sensi-
tive to LMP1-induced intracellular redistribution (Fig. 6
C). These results suggest the possibility that activation of
nuclear export machinery could be involved in the LMP1-
induced intracellular redistribution of E2F4 from the nu-
cleus to the cytoplasm.
 
LMP1 facilitates binding between E2F4 and CRM1
 
To seek mechanistic evidence that LMP1 promotes nuclear
export machinery, we next examined the binding between
E2F4 and CRM1 in the presence or absence of LMP1 using
the LMP1-inducible cell lines. As shown in Fig. 6 D, the ex-
pression of LMP1 significantly increased the binding be-
tween endogenous E2F4 and endogenous CRM1 proteins
(Fig. 6 D, lanes 1 and 2). This effect was specific to LMP1,
because we were unable to see increased interaction between
CRM1 and E2F4 in the control cells (Fig. 6 B, lanes 1 and
2). We were also able to see increased interaction between
endogenous CRM1 and endogenous Ets2 in the LMP1 ex-
pressing cells (Fig. 6 E, lanes 1 and 2). In contrast, we were
unable to see any increased interaction between CRM1 and
other nuclear shuttling proteins, such as p27
 
Kip1
 
 or cyclinB1,
in the same cell lysates (Fig. 6 D, lanes 1 and 2). Because
LMP1 does not increase the level of CRM1 (Fig. 6, D and
E, lanes 1 and 2), it is likely that LMP1 modifies CRM1/
E2F4 and Ets2 through the signaling activated by LMP1.
 
CTAR1 and CTAR2 domains are required for
LMP1-induced intracellular redistribution of E2F4
from the nucleus to the cytoplasm
 
LMP1 is composed of six transmembrane domains and a
long carboxy-terminal cytoplasmic segment. The region
containing the six transmembrane domains mediates its oli-
gomerization in the cytoplasmic membrane, resulting in the
constitutive activation of the downstream signals (Eliopou-
los and Young, 2001). There are at least two functional do-
mains (CTAR1 and CTAR2) in the cytoplasmic tail of
LMP1, which activate multiple signal transduction pathways
(Brown et al., 2001; Schultheiss et al., 2001; Thorley-Law-
son, 2001). Therefore, we examined the effect of a series of
LMP1 mutants lacking CTAR1 and/or CTAR2 domain on
the subcellular localization of E2F4 (Fig. 7 A). As shown in
Fig. 7 B, LMP1 mutants lacking CTAR1 and/or CTAR2
domain failed to induce cytoplasmic accumulation of E2F4,
suggesting that the signaling from both CTAR1 and
CTAR2 domains of LMP1 are required for intracellular re-
distribution of E2F4. This is consistent with a previous ob-
servations that the mutant LMP1 lacking CTAR2 failed to
immortalize MEFs (Xin et al., 2001), and both CTAR1 and
CTAR2 domains are necessary for efficient B cell immortal-
ization (Eliopoulos and Young, 2001).
Figure 5. LMP1 induces intracellular redistribution of endogenous 
Ets2 and E2F4 proteins. (A) LMP1-inducible cell line was established 
using SVts8 cells and Ecdyson inducible system (lanes 1 and 2). 
LMP1 expression was induced by the incubation with 0.5  g/ml of 
Ecdyson homologue, Ponasteron A for 2 d, and levels were compared 
with that of EBV-positive (lane 4) and -negative (lane 3) human B 
cells. MEK was used here as a loading control. (B) LMP1-inducible 
cell line described in A, was treated with (lanes 2 and 4) or without 
(lanes 1 and 3) 0.5  g/ml of Ponasteron A for 2 d. Next, both 
cytoplasmic (lanes 1 and 2) and nuclear (lanes 3 and 4) fractions 
were prepared and the levels of endogenous E2F4 and Ets2 were 
analyzed.  -Tubulin and LaminA/C were used here as cytoplasmic 
or nuclei marker, respectively. (C) Early passage (38 PDLs) HDFs 
expressing ecotropic receptor were infected with a retrovirus encoding 
LMP1 (lanes 2 and 4) or control vector (lanes 1 and 3). 4 d after 
infection, both cytoplasmic (lanes 1 and 2) and nuclear (lanes 3 and 
4) fractions were prepared and the levels of endogenous E2F4 and 
Ets2 were analyzed.  -Tubulin and LaminA/C were used here as 
cytoplasmic or nuclei marker, respectively. (D) Both cytoplasmic 
and nuclear fractions were prepared from BL41 cells (EBV negative) 
and BL41   B95 cells (EBV positive). The levels of endogenous 
E2F4 were analyzed by Western blotting.  -Tubulin and Sp1 were 
used here as cytoplasmic or nuclei marker, respectively. LMP1 
expression was confirmed by anti-LMP1 antibody.T
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It has been shown that CTAR1 and CTAR2 domains
have ability to activate multiple signal transduction path-
ways, such as p38 MAPK-, JNK-, MEK-, AKT-, or NF-
 
 
 
B–pathway (Roberts and Cooper, 1998; Eliopoulos and
Young, 2001; Thorley-Lawson, 2001; Fukuda et al., 2002;
Dowson et al., 2003). To narrow down the signaling path-
ways that required for LMP1-induced intracellular redistri-
bution of transcription factor, we tested whether specific in-
hibitors of these signaling pathways have any impact on the
subcellular localization of E2F4. As shown in Fig. 7 C, treat-
ment with U0126, a specific inhibitor of MEK1/2, signifi-
cantly reduced the LMP1 activity on the redistribution of
E2F4. Similar effects were seen using another MEK1/2 in-
hibitor, U0125 (unpublished data). However, other phar-
macological inhibitors such as, rapamycin (AKT inhibitor),
SB203580 (p38MAPK inhibitor), or LY294002 (PI3K in-
hibitor), did not have significant impact on the LMP1 activ-
ity. Moreover, a recent report demonstrated that inhibition
of NF-
 
 
 
B signaling override Ras-induced senescence (Dajee
et al., 2003). Thus, it is unlikely that LMP1 blocks
p16
 
INK4a
 
–RB pathway through activating the NF- B signal-
ing pathway. Together, these results suggest that MEK1/2
pathway may be, at least partly, involved in the LMP1-
induced intracellular redistribution of E2F4.
To evaluate the impact of the LMP1-induced intracellu-
lar redistribution of E2F4 on cell growth, we next tested
whether or not ectopic expression of NLS–E2F4 can coun-
teract LMP1-induced cell proliferation. Because E2F4 acts
as a repressor complex through interacting with pRB family
proteins, we coexpressed unphosphorylated form of pRB
with NLS–E2F4 in early passage TIG-3 cells. LMP1 ex-
pression significantly increased the cell number even in the
presence of unphosphorylated form of pRB (Fig. 7 D, lane
3). This effect was completely blocked by coexpression of
NLS–E2F4, whereas coexpression of wild-type E2F4 did
not have a significant effect on cell growth (Fig. 7 D, lanes
4 and 5). These results demonstrate the relevance of LMP1-
induced intracellular redistribution of E2F4 to LMP1-depen-
dent cell proliferation. 
Discussion
Here, we used human fibroblasts as a model system to un-
derstand the signaling pathways that induce Ras-induced
senescence and to elucidate how these pathways are blocked
in cancer cells. Although p16
INK4a per se is not a critical
player in Ras-induced senescence in mouse fibroblasts
(Malumbres et al., 2000; Krimpenfort et al., 2001; Seoane
et al., 2001; Sharpless et al., 2001; Stallet et al., 2001),
p16
INK4a seems to be more important in human fibroblasts.
For example, primary HDFs from members of melanoma
prone family lacking functional p16
INK4a gene are resistant
to Ras-induced senescence, although these cells retain a
functional p14
ARF–p53 pathway (Brookes et al., 2002;
Huot et al., 2002). Unlike other DNA tumor virus onco-
proteins, which possess immortalizing activity, LMP1 does
not bind to pRB but instead blocks the expression of
p16
INK4a gene in human fibroblasts (Yang et al., 2000b).
This might correlate with observations that LMP1 is associ-
ated with nasopharyngeal carcinoma, where p16
INK4a ex-
pression is frequently decreased without having mutation in
p16
INK4a gene (Sun et al., 1995; Gulley et al., 1998). This
Figure 6. LMP1 induces dissociation of E2F4 from pRB family proteins. (A and B) LMP1-inducible 
cell line (A) and Svts8 cells (B) were treated with (lane 2) or without (lane 1) 0.5  g/ml of Ponasteron 
A for 2 d. Next, cell lysates were immunoblotted directly with antibodies shown right (lysate) or after 
immunoprecipitated with anti-E2F4 antibody (IP). (C) E2F4-WT or E2F4-WT fused to NLS sequence 
(NLS–E2F4) or E2F4  NES (68, 70A E2F4s1) was coexpressed with or without GFP-tagged LMP1 
in SVts8 cells. E2F4 was detected by immunostaining with anti-E2F4 antibody and the histograms 
indicating the percentage of nuclei that were positive (N ) or negative (N ) for E2F4 expression 
were shown. Error bars indicate SD. (D and E) LMP1-inducible cell line was treated with (lane 2) or 
without (lane 1) 0.5  g/ml of Ponasteron A for 2 d. Next, cell lysates were immunoblotted directly 
with antibodies shown right (lysate) or after immunoprecipitated with antibodies shown left (IP).T
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evidence prompted us to examine how LMP1 of EBV
blocks p16
INK4a expression in human fibroblasts.
Here, we show that LMP1 blocks Ets2 transcriptional ac-
tivity through promoting a CRM1-dependent intracellular
redistribution of Ets2 from the nucleus to the cytoplasm,
thereby reducing the level of p16
INK4a expression (Figs. 1, 2,
5, and 6). Because p16
INK4a expression is also regulated by
other factors such as bmi-1, JunB, 14–3-3 , and SNF5 (Ja-
cobs et al., 1999; Dellambra et al., 2000; Passegue and Wag-
ner, 2000; Betz et al., 2002), LMP1 may affect these tran-
scription factors as well. However, we found here that
LMP1 also targets downstream mediators of p16
INK4a–RB
pathway. It has been suggested that the p16
INK4a-induced
growth arrest requires a function provided by a complex that
contains p107 or p130, and E2F4 or E2F5 (Bruce et al.,
2000; Gaubatz et al., 2000). Although inactivation of all
three activator E2Fs, E2F1–3, causes a G1 arrest in MEFs
(Wu et al., 2001), MEFs lacking both repressor E2Fs, E2F4/5,
grow normally but are insensitive to a p16
INK4a-induced G1
arrest (Gaubatz et al., 2000). This suggests that E2F4/5 are
essential downstream mediators of p16
INK4a-induced growth
arrest pathway.
Our results shown here clearly demonstrate that LMP1
blocks the function of E2F4/5 by promoting a CRM1-
dependent intracellular redistribution of E2F4/5 from the
nucleus to the cytoplasm. Because E2F4/5 lacks an NLS, E2F4/5
requires binding to NLS-containing proteins for nuclear
localization (Trimarchi and Lees, 2002). Interaction between
E2F4 and pRB family proteins seems to be a key for its nu-
clear localization, because E2F4 only localizes in the cyto-
plasm in MEFs lacking both p107 and p130 (Rayman et al.,
2002). Indeed, we observed that LMP1 induces dissociation
of E2F4 from pRB family proteins (Fig. 6 A). Moreover,
LMP1 failed to promote cytoplasmic accumulation of E2F4
Figure 7. Both CTAR1/2 domains are 
required for the nuclear export of E2F4. 
(A) Schematic representation of LMP1 
mutants used for assay described in B. 
(B) Wild-type E2F4 was coexpressed 
with wild-type and a series of LMP1 
mutants in SVts8 cells. E2F4 was detected 
by immunostaining with anti-E2F4 
antibody and the histograms indicating 
the percentage of nuclei that were positive 
(N ) or negative (N ) for E2F4 expression 
were shown. (C) Wild-type E2F4 was 
coexpressed with LMP1 in the presence 
or absence of pharmacological inhibitors 
(SB203580, Rapamycin, LY294002, 
and U0126) at 10  M, 0.1 nM, 20  M, 
and 10  M, respectively. 2 d after the 
transfection, E2F4 was detected by 
immunostaining with anti-E2F4 antibody, 
and the histograms indicating the 
percentage of nuclei that were positive 
(N ) or negative (N ) for E2F4 expression 
were shown. (D) Early passage (40 PDLs) 
TIG-3 cells were transfected with plasmids 
shown at the bottom by Nucleofector 
primary cell transfection system (Amaxa 
Biosystems). Transfection efficiencies 
were nearly 100% in all the transfected 
cells. Relative cell numbers were 
calculated using the GFP-transfected 
cells (lane 1) as the reference after 3 d. 
The experiments were repeated eight 
times with similar results. (B–D) Error bars 
indicate SD. (E) Model of LMP1 effects on 
p16
INK4a–pRB pathway. Oncogenic Ras/
MAPK signaling activates Ets2 and p16
INK4a 
induction, thereby causing growth arrest/
cellular senescence. Expression of the 
LMP1 oncoprotein blocks this pathway 
by targeting Ets2 and E2F4/5 for CRM1-
dependent intracellular relocation.T
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if E2F4 is fused to NLS (Fig. 6 C). This evidence strongly
suggests that dissociation of E2F4 from pRB family proteins
is essential for LMP1-induced intracellular redistribution of
E2F4 from the nucleus to the cytoplasm. However, subcellu-
lar localization of cellular proteins is generally dependent on
the ratio of nuclear import and export. Thus, nuclear im-
port/export machinery can be affected by LMP1. Indeed,
overexpression of CRM1 alone was sufficient to promote cy-
toplasmic accumulation of E2F4 and mutation of NES se-
quences in E2F4 or treatment with LMB rendered E2F4 in-
sensitive to LMP1-induced intracellular redistribution (Figs.
4 A and 6 C). Moreover, expression of LMP1 significantly
increased the binding between endogenous CRM1 and en-
dogenous E2F4 (Fig. 6 D). Therefore, it is possible that
the increased binding between E2F4 and CRM1 is a key
for LMP1-induced cytoplasmic accumulation of E2F4, al-
though LMP1 might dissociate E2F4 from pRB family pro-
tein in a parallel pathway. Both Ets2 and E2F5 do not con-
tain typical NES sequences (Boulukos et al., 1989; Graves
and Petersen, 1998; Ducret et al., 1999; Gaubatz et al.,
2001; Sharrocks, 2001). However, it is quite possible that
both proteins contain unidentified NES sequences, because
NES is not a well-defined sequence (la Cour et al., 2003).
Indeed, we were able to see significant interaction between
endogenous Ets2 and endogenous CRM1 in LMP1-express-
ing cells (Fig. 6 E, lanes 1 and 2). This evidence strongly sug-
gests that LMP1 induces intracellular redistribution of Ets2
through, at least partly, increasing the binding between Ets2
and CRM1. It is also important to note that we were unable
to see cytoplasmic accumulation of Ets2 in serum-stimulated
cells (unpublished data). Moreover, LMP1-induced intracel-
lular redistribution of Ets2 and E2F4 was also seen in the
cells arrested in G1 phase (unpublished data), precluding the
possibility that these effects may be secondary consequences
of cell cycle progression induced by LMP1.
Together, it is evident that LMP1-induced intracellular
redistribution has at least two effects on the p16
INK4a–RB
pathway: (1) inhibition of p16
INK4a expression and (2)
blocking the function of downstream mediators of the
p16
INK4a–RB pathway (Fig. 7 E, model). It is interesting to
note that other NES-containing proteins, such as p27
Kip1
(Fig. 2 B, 3 and 4), are resistant to LMP1-induced intracel-
lular redistribution. Moreover, we were unable to see any in-
crease of binding between CRM1 and p27
Kip1 (Fig. 6 D).
Similar results were seen in interaction between CRM1 and
cyclinB1, which is also known as another NES-containing
protein (Fig. 6 D), suggesting that there must be some target
specificity of LMP1-induced intracellular redistribution.
Because both CTAR1 and CTAR2 (CTAR1/2) domains
are required for LMP1-induced intracellular redistribution,
multiple signal transduction pathways are likely to be in-
volved in LMP1-induced intracellular redistribution of Ets2
and E2F4/5 (Fig. 7, A–C). U0126 and U0125, both are spe-
cific inhibitors of MEK1/2 pathway, efficiently attenuated
the activity of LMP1 on intracellular redistribution of E2F4,
whereas other pharmacological inhibitors did not have sig-
nificant impact on LMP1 activity (Fig. 7 C). This suggests
that LMP1 may induce intracellular redistribution of tran-
scription factors, at least partly, through MEK1/2 pathways.
Although further work is required to understand how signal-
ing activated by CTAR1/2 induces Ets2 and E2F4 binding
to CRM1 in future studies, our work reveals the novel activ-
ity of LMP1 oncoprotein. In conclusion, this paper provides
the first evidence that the viral oncoprotein blocks p16
INK4a–
RB pathway through targeting certain transcription factors
for CRM1-dependent intracellular redistribution. These
findings would provide a new insight into how viral onco-
protein can deregulate cell proliferation leading to cancer.
Materials and methods
Cell culture, retrovirus production, and transfection
TIG-3 and Hs68 strains of primary HDFs (Ohtani et al., 2001), human im-
mortalized fibroblast cell line SVts8 cells (Hara et al., 1996), EH1 cells
(McConnell et al., 1999), and HEK 293T cells were cultured in DME sup-
plemented with 10% FBS. Human B cells were cultured in RPMI medium
supplemented with 10% FBS. Cells were transfected with expression vec-
tors by a modified calcium phosphate method (Chen and Okayama,
1987). Retroviruses were generated by cotransfection of pSIG helper plas-
mid and H-RasV12pBABE-puro or LMP1pBABE-puro vectors into HEK
293T cells, and the viruses were infected into Hs68 cells expressing an
ecotropic retrovirus receptor as described previously (Roussel et al., 1996).
Transfections for HDFs were performed using the Nucleofector primary
cell transfection system (Amaxa Biosystems) according to the manufac-
turer’s instructions.
Luciferase reporter assays
Luciferase reporter activities driven by the human p16
INK4A gene promoter
(Ohtani et al., 2001), the human Rb gene promoter, and 36 tandem repeats
of Ets binding sites were assayed using SVts8 cells as described previously
(Ohtani et al., 2001). Effector plasmids were cotransfected as indicated in
the figures, along with a standard amount of the MMLV-lacZ control plas-
mid. Cells were harvested 48 h after transfection and assayed for luciferase
and  -galactosidase. Luciferase activities were normalized to the corre-
sponding  -galactosidase activity.
ChIPs assay
ChIP assays were performed as reported previously (Ohtani et al., 2001).
After immunoprecipitation with a polyclonal antiserum (#57) against Ets2
(Ohtani et al., 2001), the recovered DNA was analyzed by PCR with prim-
ers flanking the putative Ets binding site in the p16 promoter: 5 -TGCTCG-
GAGTTAATAGCACC-3  and 5 -CTCCATGCTGCTCCCCGCCG-3 .
Antibodies and protein analysis
Immunoblotting and immunoprecipitation were performed as described
previously (Sugimoto et al., 1999) with primary antibodies against p16
INK4A
(Oncogene Research Products), Ras (Calbiochem), MEK1/2 (New England
Biolabs, Inc.), phospho-MEK1/2 (New England Biolabs, Inc.), Ets2 (poly-
clonal antibody; Santa Cruz Biotechnology, Inc.; mAb: 10B3; Sanij et al.,
2003), LMP1 (LMP025) Lamin A/C (Santa Cruz Biotechnology, Inc.), E2F4
(Santa Cruz Biotechnology, Inc.),  -tubulin (Sigma-Aldrich), Flag M2
(Sigma-Aldrich), RB (BD Biosciences), Phospho-RB (Ser780; Cell Signal-
ing), Phospho-RB (Ser795; Cell Signaling), Phospho-RB (Ser807/811; Cell
Signaling), p107 (Santa Cruz Biotechnology, Inc.), p130 (Santa Cruz Bio-
technology, Inc.), Sp1 (Santa Cruz Biotechnology, Inc.), and CRM1 (Santa
Cruz Biotechnology, Inc.). The nuclear and cytoplasmic fractions were
prepared using NE-PER nuclear cytoplasmic extraction reagents (Pierce
Chemical Co.) as described previously (Chen et al., 2002).
Immunofluorescence and BrdU incorporation
Immunofluorescence analyses were performed as described previously
(Llanos et al., 2001) using primary antibodies against Ets2 (Santa Cruz
Biotechnology, Inc.), E2F4 (Santa Cruz Biotechnology, Inc.), Id1 (Santa
Cruz Biotechnology, Inc.), LMP1(LMP025), Flag M2 (Sigma-Aldrich), and
HA (Roche). Alexa Fluor–546 and –488 (Molecular Probes) and tetra-
methylrhodamine (DakoCytomation) were used as second antibodies.
BrdU incorporation assays were performed as reported previously
(Gaubatz et al., 2001).
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